From lab to law: emerging applications, potential benefits, evolving regulatory framework and challenges for engineered probiotics.
Saved in:
| Title: | From lab to law: emerging applications, potential benefits, evolving regulatory framework and challenges for engineered probiotics. |
|---|---|
| Authors: | Di Pierro F; Microbiota International Clinical Society, Turin, Italy. f.dipierro@vellejaresearch.com.; Scientific and Research Department, Velleja Research, Milan, Italy. f.dipierro@vellejaresearch.com.; Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy. f.dipierro@vellejaresearch.com., Thacharodi A; Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, Houston, TX, USA.; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA., Kumaraswami M; Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, Houston, TX, USA.; Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA., Suvorov A; Federal State Budgetary Scientific Institution Institute of Experimental Medicine, St. Petersburg, Russia., Zupet J; Eustone Research Center, Ljubljana, Slovenia., Zerbinati N; Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy. |
| Source: | Microbial cell factories [Microb Cell Fact] 2026 Apr 13; Vol. 25 (1). Date of Electronic Publication: 2026 Apr 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101139812 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2859 (Electronic) Linking ISSN: 14752859 NLM ISO Abbreviation: Microb Cell Fact Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
